{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:55:09Z","timestamp":1791248109842,"version":"4.1.0"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1097\/ftd.0b013e31825c2703","type":"journal-article","created":{"date-parts":[[2012,6,6]],"date-time":"2012-06-06T10:52:35Z","timestamp":1338979955000},"page":"477-480","source":"Crossref","is-referenced-by-count":8,"title":["Determination of Inosine Triphosphate Pyrophosphatase Phenotype in Human Red Blood Cells Using HPLC"],"prefix":"10.1097","volume":"34","author":[{"given":"Antony","family":"Citterio-Quentin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Paul","family":"Salvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roselyne","family":"Boulieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-17-20210129","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/FTD.0b013e31821a7c34","article-title":". Association between adverse effects under azathioprine therapy and inosine triphosphate pyrophosphatase activity in patients with chronic inflammatory bowel disease.","volume":"33","author":"Shipkova","year":"2011","journal-title":"Ther Drug Monit"},{"key":"R2-17-20210129","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/FTD.0b013e3180308554","article-title":". Analysis of ITPA phenotype-genotype correlation in the Bulgarian population revealed a novel gene variant in exon 6.","volume":"29","author":"Atanasova","year":"2007","journal-title":"Ther Drug Monit"},{"key":"R3-17-20210129","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00228-011-1133-1","article-title":". Epistatic interactions between thiopurine methyltransferase (TPMT) and inosine triphosphate pyrophosphatase (ITPA) variations determine 6-mercaptopurine toxicity in Indian children with acute lymphoblastic leukemia.","volume":"68","author":"Dorababu","year":"2012","journal-title":"Eur J Clin Pharmacol"},{"key":"R4-17-20210129","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00008571-200403000-00006","article-title":". Adverse drug reactions to azathioprine therapy are associated with polymorphism in the gene encoding inosine triphosphate pyrophosphatase (ITPase).","volume":"14","author":"Marinaki","year":"2004","journal-title":"Pharmacogenetics"},{"key":"R5-17-20210129","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/clpt.2008.154","article-title":". Genetic polymorphism of inosine triphosphate pyrophosphatase is a determinant of mercaptopurine metabolism and toxicity during treatment for acute lymphoblastic leukemia.","volume":"85","author":"Stocco","year":"2009","journal-title":"Clin Pharmacol Ther"},{"key":"R6-17-20210129","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1373\/clinchem.2005.057158","article-title":". Association of inosine triphosphatase 94CA and thiopurine S-methyltransferase deficiency with adverse events and study drop-outs under azathioprine therapy in a prospective Crohn disease study.","volume":"51","author":"von Ahsen","year":"2005","journal-title":"Clin Chem"},{"key":"R7-17-20210129","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1472-8206.2009.00770.x","article-title":". Association between inosine triphosphate pyrophosphohydrolase deficiency and azathioprine-related adverse drug reactions in the Chinese kidney transplant recipients.","volume":"24","author":"Xiong","year":"2009","journal-title":"Fund Clin Pharmacol"},{"key":"R8-17-20210129","first-page":"247","article-title":". A pharmacogenetics study of TPMT and ITPA genes detects a relationship with side effects and clinical response in patients with inflammatory bowel disease receiving Azathioprine.","volume":"20","author":"Zabala-Fernandez","year":"2011","journal-title":"J Gastrointest Liver Dis"},{"key":"R9-17-20210129","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.cgh.2005.10.019","article-title":". Inosine triphosphate pyrophosphatase and thiopurine s-methyltransferase genotypes relationship to azathioprine-induced myelosuppression.","volume":"4","author":"Zelinkova","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R10-17-20210129","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1373\/clinchem.2004.039685","article-title":". Rapid detection of ITPA 94CA and IVS2 21AC gene mutations by real-time fluorescence PCR and in vitro demonstration of effect of ITPA IVS2 21AC polymorphism on splicing efficiency.","volume":"50","author":"Heller","year":"2004","journal-title":"Clin Chem"},{"key":"R11-17-20210129","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1074\/jbc.M011084200","article-title":". Cloning, expression, and characterization of a human inosine triphosphate pyrophosphatase encoded by the itpa gene.","volume":"276","author":"Lin","year":"2001","journal-title":"J Biol Chem"},{"key":"R12-17-20210129","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1373\/clinchem.2005.059501","article-title":". Measurement of erythrocyte inosine triphosphate pyrophosphohydrolase (ITPA) activity by HPLC and correlation of ITPA genotype-phenotype in a Caucasian population.","volume":"52","author":"Shipkova","year":"2006","journal-title":"Clin Chem"},{"key":"R13-17-20210129","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s00439-002-0798-z","article-title":". Genetic basis of inosine triphosphate pyrophosphohydrolase deficiency.","volume":"111","author":"Sumi","year":"2002","journal-title":"Hum Genet"},{"key":"R14-17-20210129","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1136\/gut.2004.055947","article-title":". ITPA genotyping test does not improve detection of Crohns disease patients at risk of azathioprine6-mercaptopurine induced myelosuppression.","volume":"54","author":"Allorge","year":"2005","journal-title":"Gut"},{"key":"R15-17-20210129","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1111\/j.1365-2036.2006.02853.x","article-title":". Pharmacogenetics of thiopurine therapy in paediatric IBD patients.","volume":"23","author":"De Ridder","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"R16-17-20210129","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1097\/00008571-200411000-00010","article-title":". Lack of association between the ITPA 94CA polymorphism and adverse effects from azathioprine.","volume":"14","author":"Gearry","year":"2004","journal-title":"Pharmacogenetics"},{"key":"R17-17-20210129","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1136\/gut.2005.074930","article-title":". Pharmacogenetics during standardised initiation of thiopurine treatment in inflammatory bowel disease.","volume":"55","author":"Hindorf","year":"2006","journal-title":"Gut"},{"key":"R18-17-20210129","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s00228-009-0630-y","article-title":". TPMT but not ITPA gene polymorphism influences the risk of azathioprine intolerance in renal transplant recipients.","volume":"65","author":"Kurzawski","year":"2009","journal-title":"Eur J Clin Pharmacol"},{"key":"R19-17-20210129","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0009-8981(90)90206-8","article-title":". Inosine triphosphate pyrophosphohydrolase deficiency in a kindred with adenosine deaminase deficiency.","volume":"188","author":"Duley","year":"1990","journal-title":"Clin Chim Acta"},{"key":"R20-17-20210129","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1093\/clinchem\/47.5.956","article-title":". Phenotype determination of thiopurine methyltransferase in erythrocytes by HPLC.","volume":"47","author":"Boulieu","year":"2001","journal-title":"Clin Chem"},{"key":"R21-17-20210129","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.2217\/14622416.8.9.1221","article-title":"Pharmacogenetic significance of inosine triphosphatase.","volume":"8","author":"Bierau","year":"2007","journal-title":"Pharmacogenomics"},{"key":"R22-17-20210129","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.jmb.2009.07.051","article-title":". Functional study of the P32T ITPA variant associated with drug sensitivity in humans.","volume":"392","author":"Stepchenkova","year":"2009","journal-title":"J Biol Mol"},{"key":"R23-17-20210129","first-page":"262","article-title":". Quantitative in vitro and in vivo characterisation of the human P32T mutant ITPase.","volume":"1802","author":"Herting","year":"2010","journal-title":"Biochim Biophys Acta"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0b013e31825c2703","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:39:45Z","timestamp":1620952785000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007691-201208000-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0b013e31825c2703","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}